Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium: 4 sponsored US clinical trials, none currently recruiting.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, with 1 trials.

Upper-quartile sponsor footprint

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

4 total, page 1 of 1

COMPLETED Phase 3

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461
COMPLETED Phase 1

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

NCT00438984
COMPLETED Phase 2

Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

NCT00031655
COMPLETED Phase 1

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

NCT00002787

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1
Phase 3 1

Therapeutic Areas

Atypical Chronic Myeloid Leukemia, BCR-ABL Negative 1
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) 1
Blastic Phase Chronic Myelogenous Leukemia 1
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) 1
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) 1
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) 1
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities 1
Accelerated Phase Chronic Myelogenous Leukemia 1
Adult Acute Myeloid Leukemia in Remission 1
Adult Acute Lymphoblastic Leukemia in Remission 1

How the Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium early-phase archive is shaped

4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Atypical Chronic Myeloid Leukemia, BCR-ABL Negative (1 trial), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium: archived-pipeline peers nationwide

Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action Lab10xBio22nd Century Group23andMe3-C Institute for Social Development
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium page

4 registered trials is a research-attention snapshot, not an endorsement of Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium or any single study.

  • None of Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Atypical Chronic Myeloid Leukemia, BCR-ABL Negative is the condition Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atypical Chronic Myeloid Leukemia, BCR-ABL Negative trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.